aspirin has been researched along with Subarachnoid Hemorrhage in 85 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Subarachnoid Hemorrhage: Bleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurological deficits and reduced mental status.
| Excerpt | Relevance | Reference |
|---|---|---|
| "There is an association between aspirin use and subarachnoid hemorrhage in patients with intracranial aneurysms." | 9.22 | A meta-analysis of aspirin and subarachnoid hemorrhage in patients with intracranial aneurysms yields different results to the general population. ( Birks, J; Bulters, D; Ewbank, F, 2022) |
| "Although some previous studies suggested that aspirin may potentially reduce the risk of subarachnoid hemorrhage, our meta-analysis found an association between the reduction of risk of aneurysmal subarachnoid hemorrhage." | 9.12 | Relationship between aspirin use and subarachnoid hemorrhage: A systematic Review and meta-analysis. ( Florez, WA; García-Ballestas, E; Joaquim, A; Maeda, F; Martinez-Perez, R; Moscote-Salazar, LR; Pavlov, O; Tsimpas, A, 2021) |
| "To assess the association between aspirin use and risk of aneurysmal subarachnoid hemorrhage (aSAH)." | 9.05 | Association Between Aspirin Use and Risk of Aneurysmal Subarachnoid Hemorrhage: A Meta-analysis. ( Chen, C; He, Y; Li, Y; Qian, C; Zhang, B, 2020) |
| "Recent studies have suggested that the use of low-dose aspirin may reduce the risk of aneurysmal subarachnoid hemorrhage (aSAH)." | 8.95 | Aspirin and Risk of Subarachnoid Hemorrhage: Systematic Review and Meta-Analysis. ( Griessenauer, CJ; Moore, JM; Ogilvy, CS; Phan, K; Thomas, AJ, 2017) |
| "All RCTs investigating the effect of cilostazol on secondary prevention of ischemic stroke were obtained." | 8.90 | The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population--an updated meta-analysis. ( Chen, S; Malaguit, J; Pu, J; Shi, L; Xu, L; Zhang, J, 2014) |
| "Aneurysmal subarachnoid hemorrhage patients treated at a single institution between November 2011 and December 2017 were divided according to whether they received aspirin monotherapy or DAPT after endovascular treatment." | 7.96 | Dual antiplatelet therapy does not improve outcomes after aneurysmal subarachnoid hemorrhage compared with aspirin monotherapy. ( Almandoz, JED; Contestabile, E; Kayan, Y; Milner, AA; Mulder, M; Scholz, JM; Stiernagle, K; Tipps, ME; Wallace, AN, 2020) |
| "To determine the association between ruptured saccular aneurysms and aspirin use/aspirin dose." | 7.88 | Association between aspirin dose and subarachnoid hemorrhage from saccular aneurysms: A case-control study. ( Cai, T; Can, A; Castro, VM; Dligach, D; Du, R; Finan, S; Gainer, V; Murphy, S; Rudy, RF; Savova, G; Shadick, NA; Weiss, ST; Yu, S, 2018) |
| "OBJECTIVE Although aspirin usage may be associated with a decreased risk of rupture of cerebral aneurysms, any potential therapeutic benefit from aspirin must be weighed against the theoretical risk of greater hemorrhage volume if subarachnoid hemorrhage (SAH) occurs." | 7.85 | The impact of aspirin and anticoagulant usage on outcomes after aneurysmal subarachnoid hemorrhage: a Nationwide Inpatient Sample analysis. ( Ali Aziz-Sultan, M; Dasenbrock, HH; Du, R; Frerichs, KU; Gormley, WB; Gross, BA; Guttieres, D; Yan, SC, 2017) |
| " In this study, the authors assess the incidence of stroke or transient ischemic attack (TIA) following discontinuation of a 6-week course of clopidogrel in patients with cerebral aneurysms treated with stent-assisted techniques." | 7.78 | Incidence of cerebral ischemic events after discontinuation of clopidogrel in patients with intracranial aneurysms treated with stent-assisted techniques. ( Abel, TJ; Chalouhi, N; Hasan, DM; Jabbour, PM; Kung, DK; Rossen, JD; Thomas, J; Wassef, SN, 2012) |
| "The relationship between nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and hemorrhagic stroke (HS) remains unclear." | 7.74 | Nonaspirin nonsteroidal anti-inflammatory drugs and hemorrhagic stroke risk: the Acute Brain Bleeding Analysis study. ( Choi, NK; Jeong, SW; Park, BJ; Yoon, BW; Yu, KH, 2008) |
| "To evaluate the effect of singular or sustained hemodilution, with alpha-alpha diaspirin crosslinked hemoglobin (DCLHb), on the area of hypoperfusion after subarachnoid hemorrhage." | 7.70 | Subarachnoid hemorrhage in rats: effect of singular or sustained hemodilution with alpha-alpha diaspirin crosslinked hemoglobin on cerebral hypoperfusion. ( Cole, DJ; Drummond, JC; Jacobsen, WK; Nary, JC; Patel, PM; Reynolds, LW, 1999) |
| "This follow-up study was designed to evaluate whether the use of aspirin either before or after aneurysm rupture affects the occurrence of delayed cerebral ischemia." | 7.69 | Aspirin and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. ( Juvela, S, 1995) |
| "Treatment with aspirin also resulted in decreased expression of COX-2 within leukocytes within aneurysms as compared to peripheral blood samples." | 6.52 | Potential role of aspirin in the prevention of aneurysmal subarachnoid hemorrhage. ( Chalouhi, N; Ding, D; Hasan, DM; Starke, RM, 2015) |
| "Aspirin users were older on average than nonusers (59 years of age compared with 53 years; p = 0." | 5.32 | Influence of aspirin on outcome following aneurysmal subarachnoid hemorrhage. ( Atkinson, JL; Friedman, JA; McClelland, RL; McIver, JI; Meyer, FB; Nichols, DA; Pichelmann, MA; Piepgras, DG; Toussaint, LG; Wijdicks, EF, 2004) |
| "There is an association between aspirin use and subarachnoid hemorrhage in patients with intracranial aneurysms." | 5.22 | A meta-analysis of aspirin and subarachnoid hemorrhage in patients with intracranial aneurysms yields different results to the general population. ( Birks, J; Bulters, D; Ewbank, F, 2022) |
| "Although some previous studies suggested that aspirin may potentially reduce the risk of subarachnoid hemorrhage, our meta-analysis found an association between the reduction of risk of aneurysmal subarachnoid hemorrhage." | 5.12 | Relationship between aspirin use and subarachnoid hemorrhage: A systematic Review and meta-analysis. ( Florez, WA; García-Ballestas, E; Joaquim, A; Maeda, F; Martinez-Perez, R; Moscote-Salazar, LR; Pavlov, O; Tsimpas, A, 2021) |
| "To assess the association between aspirin use and risk of aneurysmal subarachnoid hemorrhage (aSAH)." | 5.05 | Association Between Aspirin Use and Risk of Aneurysmal Subarachnoid Hemorrhage: A Meta-analysis. ( Chen, C; He, Y; Li, Y; Qian, C; Zhang, B, 2020) |
| "Recent studies have suggested that the use of low-dose aspirin may reduce the risk of aneurysmal subarachnoid hemorrhage (aSAH)." | 4.95 | Aspirin and Risk of Subarachnoid Hemorrhage: Systematic Review and Meta-Analysis. ( Griessenauer, CJ; Moore, JM; Ogilvy, CS; Phan, K; Thomas, AJ, 2017) |
| "All RCTs investigating the effect of cilostazol on secondary prevention of ischemic stroke were obtained." | 4.90 | The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population--an updated meta-analysis. ( Chen, S; Malaguit, J; Pu, J; Shi, L; Xu, L; Zhang, J, 2014) |
| "Aneurysmal subarachnoid hemorrhage patients treated at a single institution between November 2011 and December 2017 were divided according to whether they received aspirin monotherapy or DAPT after endovascular treatment." | 3.96 | Dual antiplatelet therapy does not improve outcomes after aneurysmal subarachnoid hemorrhage compared with aspirin monotherapy. ( Almandoz, JED; Contestabile, E; Kayan, Y; Milner, AA; Mulder, M; Scholz, JM; Stiernagle, K; Tipps, ME; Wallace, AN, 2020) |
| "Aspirin prevented aneurysm rupture in a mouse intracranial aneurysm model, while cilostazol did not." | 3.88 | Prevention Effect of Antiplatelets on Aneurysm Rupture in a Mouse Intracranial Aneurysm Model. ( Hiramatsu, H; Hokamura, K; Kamio, Y; Kimura, T; Makino, H; Namba, H; Suzuki, T; Umemura, K; Yamasaki, T, 2018) |
| "To determine the association between ruptured saccular aneurysms and aspirin use/aspirin dose." | 3.88 | Association between aspirin dose and subarachnoid hemorrhage from saccular aneurysms: A case-control study. ( Cai, T; Can, A; Castro, VM; Dligach, D; Du, R; Finan, S; Gainer, V; Murphy, S; Rudy, RF; Savova, G; Shadick, NA; Weiss, ST; Yu, S, 2018) |
| " In patients hospitalized for ischaemic stroke, 30-day mortality was reduced in users of both aspirin and clopidogrel, but not in users of aspirin alone." | 3.88 | Pre-admission use of platelet inhibitors and short-term stroke mortality: a population-based cohort study. ( Christiansen, CF; Grove, EL; Henderson, VW; Horváth-Puhó, E; Schmidt, M; Sørensen, HT; Würtz, M, 2018) |
| "OBJECTIVE Although aspirin usage may be associated with a decreased risk of rupture of cerebral aneurysms, any potential therapeutic benefit from aspirin must be weighed against the theoretical risk of greater hemorrhage volume if subarachnoid hemorrhage (SAH) occurs." | 3.85 | The impact of aspirin and anticoagulant usage on outcomes after aneurysmal subarachnoid hemorrhage: a Nationwide Inpatient Sample analysis. ( Ali Aziz-Sultan, M; Dasenbrock, HH; Du, R; Frerichs, KU; Gormley, WB; Gross, BA; Guttieres, D; Yan, SC, 2017) |
| " In this study, the authors assess the incidence of stroke or transient ischemic attack (TIA) following discontinuation of a 6-week course of clopidogrel in patients with cerebral aneurysms treated with stent-assisted techniques." | 3.78 | Incidence of cerebral ischemic events after discontinuation of clopidogrel in patients with intracranial aneurysms treated with stent-assisted techniques. ( Abel, TJ; Chalouhi, N; Hasan, DM; Jabbour, PM; Kung, DK; Rossen, JD; Thomas, J; Wassef, SN, 2012) |
| "Long-term dipyridamole use and new LDA use were associated with an increased risk of subarachnoid hemorrhage." | 3.76 | Antiplatelet drugs and risk of subarachnoid hemorrhage: a population-based case-control study. ( Christensen, S; Christiansen, CF; Johansen, MB; Lash, TL; Schmidt, M; Sørensen, HT, 2010) |
| "The relationship between nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and hemorrhagic stroke (HS) remains unclear." | 3.74 | Nonaspirin nonsteroidal anti-inflammatory drugs and hemorrhagic stroke risk: the Acute Brain Bleeding Analysis study. ( Choi, NK; Jeong, SW; Park, BJ; Yoon, BW; Yu, KH, 2008) |
| " We report our initial experience using a new self-expanding easy-to-place nitinol stent (Enterprise) in the treatment of wide-neck intracranial aneurysms." | 3.74 | A new self-expandable nitinol stent for the treatment of wide-neck aneurysms: initial clinical experience. ( Beute, GN; Peluso, JP; Sluzewski, M; van Rooij, WJ, 2008) |
| "Between August 2001 and January 2004 we treated nine acute subarachnoid hemorrhage (SAH) patients with a combination of stents and platinum coils." | 3.73 | [Stenting plus coiling: dangerous or helpful?]. ( Dörfler, A; Forsting, M; Gizewski, E; Stolke, D; Wanke, I, 2005) |
| "A previous study indicated that diaspirin-crosslinked hemoglobin (DCLHb) decreases cerebral ischemia after subarachnoid hemorrhage." | 3.70 | Subarachnoid molecular hemoglobin after subarachnoid hemorrhage in rats: effect on the area of hypoperfusion. ( Cole, DJ; Cross, LM; Drummond, JC; McKay, LD; Patel, PM, 1998) |
| "To evaluate the effect of singular or sustained hemodilution, with alpha-alpha diaspirin crosslinked hemoglobin (DCLHb), on the area of hypoperfusion after subarachnoid hemorrhage." | 3.70 | Subarachnoid hemorrhage in rats: effect of singular or sustained hemodilution with alpha-alpha diaspirin crosslinked hemoglobin on cerebral hypoperfusion. ( Cole, DJ; Drummond, JC; Jacobsen, WK; Nary, JC; Patel, PM; Reynolds, LW, 1999) |
| "These prospective data indicate that women who take 1 to 6 aspirin per week have a reduced risk of large-artery occlusive infarction, but those who use 15 or more aspirin per week have an increased risk of subarachnoid hemorrhage." | 3.70 | Prospective study of aspirin use and risk of stroke in women. ( Colditz, GA; Hennekens, CH; Iso, H; Manson, JE; Rexrode, KM; Speizer, FE; Stampfer, MJ; Willett, WC, 1999) |
| "This follow-up study was designed to evaluate whether the use of aspirin either before or after aneurysm rupture affects the occurrence of delayed cerebral ischemia." | 3.69 | Aspirin and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. ( Juvela, S, 1995) |
| "OBJECTIVE Clinical vasospasm and delayed cerebral ischemia (DCI) are devastating complications of aneurysmal subarachnoid hemorrhage (aSAH)." | 2.87 | Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia. ( Allan, L; Broderick, J; Brown, RD; Chalouhi, N; Chimowitz, M; Derdeyn, CP; Hasan, D; Jabbour, P; Leira, EC; Nagahama, Y; Nakagawa, D; Starke, RM; Torner, JC; Zanaty, M, 2018) |
| "Treatment with aspirin also resulted in decreased expression of COX-2 within leukocytes within aneurysms as compared to peripheral blood samples." | 2.52 | Potential role of aspirin in the prevention of aneurysmal subarachnoid hemorrhage. ( Chalouhi, N; Ding, D; Hasan, DM; Starke, RM, 2015) |
| "Aspirin use was associated with SAH resulting in death (HR, 1." | 1.91 | Aspirin and Subarachnoid Haemorrhage in the UK Biobank. ( Birks, J; Bulters, D; Ewbank, F; Gaastra, B; Galea, I; Hall, S, 2023) |
| "The ruptured aneurysms were four saccular, two blister-like and one dissecting, six in the anterior and one in posterior circulation." | 1.56 | Flow diverter stents with hydrophilic polymer coating for the treatment of acutely ruptured aneurysms using single antiplatelet therapy: Preliminary experience. ( Carriero, A; Cossandi, C; Del Sette, B; Galbiati, A; Guzzardi, G; Paladini, A; Stanca, C, 2020) |
| "Among those developing intracranial hemorrhage, limited data are available to guide clinicians with antithrombotic reinitiation." | 1.56 | Warfarin Reinitiation After Intracranial Hemorrhage: A Case Series of Heart Valve Patients. ( Bungard, TJ; Butcher, K; Hodgson, M; Schultz, K; Wan, A, 2020) |
| "Aspirin use was independently associated with reduced DCI risk (P < ." | 1.51 | Post-treatment Antiplatelet Therapy Reduces Risk for Delayed Cerebral Ischemia due to Aneurysmal Subarachnoid Hemorrhage. ( Darkwah Oppong, M; Deuschl, C; Forsting, M; Gembruch, O; Jabbarli, R; Kaier, K; Kleinschnitz, C; Köhrmann, M; Mönninghoff, C; Pierscianek, D; Sure, U, 2019) |
| "Cerebral vasospasm was more often only mild and rates of cerebral infarctions were lower in the OTA group but not on a significant level." | 1.51 | Pain medication at ictus of subarachnoid hemorrhage-the influence of one-time acetylsalicylic acid usage on bleeding pattern, treatment course, and outcome: a matched pair analysis. ( Brawanski, N; Bruder, M; Kashefiolasl, S; Keil, F; Konczalla, J; Seifert, V; Won, SY, 2019) |
| " No duration of use or dose-response association was apparent." | 1.46 | Low-dose aspirin and risk of intracranial bleeds: An observational study in UK general practice. ( Bromley, S; Cea Soriano, L; Gaist, D; García Rodríguez, LA; Soriano-Gabarró, M, 2017) |
| "Flow diversion has revolutionised the treatment of intracranial aneurysms, and the Pipeline Embolization Device (PED) remains the only flow diverter (FD) approved in the USA." | 1.46 | First US experience with Pipeline Flex with Shield Technology using aspirin as antiplatelet monotherapy. ( Aguilar-Salinas, P; Brasiliense, LB; Hanel, RA; Sauvageau, E, 2017) |
| "The rate of cerebral aneurysm rupture was similar in male mice receiving aspirin and 15-hydroxyprostaglandin dehydrogenase inhibitor compared with females receiving aspirin and 15-hydroxyprostaglandin dehydrogenase agonist, signaling a reversal of the sex-differential response to aspirin." | 1.43 | Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice. ( Brown, RD; Chalouhi, N; Correa, T; Hasan, DM; Jabbour, PM; Starke, RM; Torner, JC; Zanaty, M, 2016) |
| "No new intracranial hemorrhages were observed in patients not receiving dual antiplatelet therapy." | 1.39 | Risk of hemorrhagic complication associated with ventriculoperitoneal shunt placement in aneurysmal subarachnoid hemorrhage patients on dual antiplatelet therapy. ( Bulsara, KR; Chalouhi, N; Hasan, DM; Howard, M; Jabbour, P; Kung, DK; Mahaney, KB; Smietana, J; Viljoen, S, 2013) |
| "The determinants of subarachnoid hemorrhage (SAH) volume and an atypical pattern of blood are not clear." | 1.38 | Predictors of hemorrhage volume and disability after perimesencephalic subarachnoid hemorrhage. ( Batjer, HH; Bendok, BR; Maas, MB; Naidech, AM; Nemeth, AJ; Rosenberg, NF, 2012) |
| "Previously, all reports of intracranial hemorrhages in MDMA abusers were associated with coingestion of other sympathomimetic drugs, or with pre-existing cerebrovascular lesions." | 1.38 | 3 cases of primary intracranial hemorrhage associated with "Molly", a purified form of 3,4-methylenedioxymethamphetamine (MDMA). ( Benveniste, RJ; Ferraro, N; Kahn, DE, 2012) |
| "The lack of reported recurrences may lead to less cautious administration of antithrombotic therapy." | 1.35 | Recurrent perimesencephalic subarachnoid hemorrhage during antithrombotic therapy. ( Fonville, S; Ramos, LM; Rinkel, GJ; van der Worp, HB, 2009) |
| "Two hundred and sixty-one cerebral aneurysms were treated in 247 patients by endovascular coil embolization from January 2001 to September 2004." | 1.33 | Intravenous administration of acetylsalicylic acid during endovascular treatment of cerebral aneurysms reduces the rate of thromboembolic events. ( Buhk, JH; Fiehler, J; Goebell, E; Grzyska, U; Kucinski, T; Ries, T; Zeumer, H, 2006) |
| "Aspirin users were older on average than nonusers (59 years of age compared with 53 years; p = 0." | 1.32 | Influence of aspirin on outcome following aneurysmal subarachnoid hemorrhage. ( Atkinson, JL; Friedman, JA; McClelland, RL; McIver, JI; Meyer, FB; Nichols, DA; Pichelmann, MA; Piepgras, DG; Toussaint, LG; Wijdicks, EF, 2004) |
| "Unfortunately, VBA transient ischemic attacks (TIAs) herald a lethal or devastating event within 5 years in 25 to 30% of patients." | 1.31 | Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: an initial experience. ( Barr, JD; Furlan, AJ; Katzan, I; Krieger, D; Markarian, GZ; Masaryk, TJ; Perl, J; Rasmussen, PA; Sila, C, 2000) |
| "Chronic subdural hematoma appears to be a suitable model for the evaluation of risk factors in the development of hemorrhage." | 1.28 | Aspirin as a risk factor for hemorrhage in patients with head injuries. ( Gratzl, O; Marbet, G; Radü, EW; Reymond, MA, 1992) |
| "Phentolamine was ineffective." | 1.26 | Mechanism of cerebral arterial contraction induced by blood constituents. ( Ohta, T; Shimizu, K; Toda, N, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (8.24) | 18.7374 |
| 1990's | 9 (10.59) | 18.2507 |
| 2000's | 20 (23.53) | 29.6817 |
| 2010's | 37 (43.53) | 24.3611 |
| 2020's | 12 (14.12) | 2.80 |
| Authors | Studies |
|---|---|
| Ewbank, F | 3 |
| Birks, J | 3 |
| Gaastra, B | 1 |
| Hall, S | 1 |
| Galea, I | 1 |
| Bulters, D | 3 |
| Shimizu, K | 2 |
| Aoki, T | 1 |
| Etminan, N | 2 |
| Hackenberg, KAM | 2 |
| Tani, S | 1 |
| Imamura, H | 1 |
| Kataoka, H | 1 |
| Sakai, N | 1 |
| Hudson, JS | 1 |
| Marincovich, AJ | 1 |
| Roa, JA | 1 |
| Zanaty, M | 3 |
| Samaniego, EA | 1 |
| Hasan, DM | 6 |
| Wan, A | 1 |
| Butcher, K | 1 |
| Hodgson, M | 1 |
| Schultz, K | 1 |
| Bungard, TJ | 1 |
| Grasso, G | 1 |
| Torregrossa, F | 1 |
| Qian, C | 1 |
| He, Y | 1 |
| Li, Y | 1 |
| Chen, C | 1 |
| Zhang, B | 1 |
| Wallace, AN | 1 |
| Kayan, Y | 1 |
| Almandoz, JED | 1 |
| Mulder, M | 1 |
| Milner, AA | 1 |
| Scholz, JM | 1 |
| Stiernagle, K | 1 |
| Contestabile, E | 1 |
| Tipps, ME | 1 |
| Guzzardi, G | 1 |
| Galbiati, A | 1 |
| Stanca, C | 1 |
| Del Sette, B | 1 |
| Paladini, A | 1 |
| Cossandi, C | 1 |
| Carriero, A | 1 |
| Florez, WA | 1 |
| García-Ballestas, E | 1 |
| Maeda, F | 1 |
| Joaquim, A | 1 |
| Pavlov, O | 1 |
| Moscote-Salazar, LR | 1 |
| Tsimpas, A | 1 |
| Martinez-Perez, R | 1 |
| Wu, Y | 1 |
| Jiang, X | 1 |
| Yu, X | 1 |
| Sebök, M | 1 |
| Hostettler, IC | 1 |
| Keller, E | 1 |
| Rautalin, IM | 1 |
| Coert, BA | 1 |
| Vandertop, WP | 1 |
| Post, R | 1 |
| Sardeha, A | 1 |
| Tjerkstra, MA | 1 |
| Regli, L | 1 |
| Verbaan, D | 1 |
| Germans, MR | 1 |
| Phan, K | 1 |
| Moore, JM | 1 |
| Griessenauer, CJ | 1 |
| Ogilvy, CS | 1 |
| Thomas, AJ | 1 |
| Cea Soriano, L | 2 |
| Gaist, D | 3 |
| Soriano-Gabarró, M | 2 |
| García Rodríguez, LA | 3 |
| Hanel, RA | 1 |
| Aguilar-Salinas, P | 1 |
| Brasiliense, LB | 1 |
| Sauvageau, E | 1 |
| Bayman, E | 1 |
| Broderick, J | 2 |
| Bromley, S | 1 |
| Nagahama, Y | 1 |
| Allan, L | 1 |
| Nakagawa, D | 1 |
| Starke, RM | 3 |
| Chalouhi, N | 5 |
| Jabbour, P | 2 |
| Brown, RD | 2 |
| Derdeyn, CP | 1 |
| Leira, EC | 1 |
| Chimowitz, M | 1 |
| Torner, JC | 2 |
| Hasan, D | 1 |
| Bruder, M | 2 |
| Won, SY | 2 |
| Wagner, M | 1 |
| Brawanski, N | 2 |
| Dinc, N | 1 |
| Kashefiolasl, S | 2 |
| Seifert, V | 2 |
| Konczalla, J | 2 |
| Würtz, M | 1 |
| Schmidt, M | 2 |
| Grove, EL | 1 |
| Horváth-Puhó, E | 1 |
| Henderson, VW | 1 |
| Christiansen, CF | 2 |
| Sørensen, HT | 2 |
| Suzuki, T | 1 |
| Kamio, Y | 1 |
| Makino, H | 1 |
| Hokamura, K | 1 |
| Kimura, T | 1 |
| Yamasaki, T | 1 |
| Hiramatsu, H | 1 |
| Umemura, K | 1 |
| Namba, H | 1 |
| Keil, F | 1 |
| Can, A | 1 |
| Rudy, RF | 1 |
| Castro, VM | 1 |
| Yu, S | 1 |
| Dligach, D | 1 |
| Finan, S | 1 |
| Gainer, V | 1 |
| Shadick, NA | 1 |
| Savova, G | 1 |
| Murphy, S | 1 |
| Cai, T | 1 |
| Weiss, ST | 1 |
| Du, R | 4 |
| Hänggi, D | 1 |
| Darkwah Oppong, M | 1 |
| Gembruch, O | 1 |
| Pierscianek, D | 1 |
| Köhrmann, M | 1 |
| Kleinschnitz, C | 1 |
| Deuschl, C | 1 |
| Mönninghoff, C | 1 |
| Kaier, K | 1 |
| Forsting, M | 2 |
| Sure, U | 1 |
| Jabbarli, R | 1 |
| Agarwal, S | 1 |
| Zhou, T | 1 |
| Frontera, J | 1 |
| Juvela, S | 3 |
| Vilanilam, G | 1 |
| Badi, M | 1 |
| Vemireddy, LP | 1 |
| Gopal, N | 1 |
| Henkes, H | 1 |
| Bhogal, P | 1 |
| Aguilar Pérez, M | 1 |
| Lenz-Habijan, T | 1 |
| Bannewitz, C | 1 |
| Peters, M | 1 |
| Sengstock, C | 1 |
| Ganslandt, O | 1 |
| Lylyk, P | 1 |
| Monstadt, H | 1 |
| Gross, BA | 2 |
| Rosalind Lai, PM | 1 |
| Frerichs, KU | 2 |
| Mahaney, KB | 1 |
| Viljoen, S | 1 |
| Smietana, J | 1 |
| Kung, DK | 2 |
| Bulsara, KR | 1 |
| Howard, M | 1 |
| Shi, L | 1 |
| Pu, J | 1 |
| Xu, L | 1 |
| Malaguit, J | 1 |
| Zhang, J | 1 |
| Chen, S | 1 |
| Ding, D | 1 |
| Pottegård, A | 1 |
| Poulsen, FR | 1 |
| Hallas, J | 1 |
| Prinz, V | 1 |
| Finger, T | 1 |
| Bayerl, S | 1 |
| Rosenthal, C | 1 |
| Wolf, S | 1 |
| Liman, T | 1 |
| Vajkoczy, P | 1 |
| Garrard, JW | 1 |
| Simm, RF | 1 |
| Bor-Seng-Shu, E | 1 |
| Nogueira, RC | 1 |
| Dasenbrock, HH | 1 |
| Yan, SC | 1 |
| Guttieres, D | 1 |
| Gormley, WB | 1 |
| Ali Aziz-Sultan, M | 1 |
| Correa, T | 1 |
| Jabbour, PM | 2 |
| Chiu, AH | 1 |
| Ramesh, R | 1 |
| Wenderoth, J | 1 |
| Davies, M | 1 |
| Cheung, A | 1 |
| Connors, CW | 1 |
| Nguyen, JD | 1 |
| van der Worp, HB | 1 |
| Fonville, S | 1 |
| Ramos, LM | 1 |
| Rinkel, GJ | 5 |
| van den Bergh, WM | 3 |
| Algra, A | 4 |
| Kerr, RS | 1 |
| Molyneux, AJ | 1 |
| Alkan, O | 1 |
| Yildirim, T | 1 |
| Kizilkiliç, O | 1 |
| Tan, M | 1 |
| Cekinmez, M | 1 |
| Johansen, MB | 1 |
| Lash, TL | 1 |
| Christensen, S | 1 |
| Dubessy, AL | 1 |
| Ursu, R | 1 |
| Maillet, D | 1 |
| Augier, A | 1 |
| Le Guilloux, J | 1 |
| Carpentier, AF | 1 |
| Belin, C | 1 |
| Naidech, AM | 1 |
| Rosenberg, NF | 1 |
| Maas, MB | 1 |
| Bendok, BR | 1 |
| Batjer, HH | 1 |
| Nemeth, AJ | 1 |
| Rossen, JD | 1 |
| Wassef, SN | 1 |
| Thomas, J | 1 |
| Abel, TJ | 1 |
| Kahn, DE | 1 |
| Ferraro, N | 1 |
| Benveniste, RJ | 1 |
| Fang, YB | 1 |
| Li, Q | 1 |
| Yang, PF | 1 |
| Huang, QH | 1 |
| Zhao, WY | 1 |
| Xu, Y | 1 |
| Hong, B | 1 |
| Liu, JM | 1 |
| Froehler, MT | 1 |
| Kurth, T | 1 |
| Kase, CS | 1 |
| Berger, K | 1 |
| Schaeffner, ES | 1 |
| Buring, JE | 1 |
| Gaziano, JM | 1 |
| Garnier, P | 1 |
| Demasles, S | 1 |
| Januel, AC | 1 |
| Michel, D | 1 |
| Conforto, AB | 1 |
| Puglia, P | 1 |
| Yamamoto, FI | 1 |
| Scaff, M | 1 |
| Toussaint, LG | 1 |
| Friedman, JA | 1 |
| Wijdicks, EF | 1 |
| Piepgras, DG | 1 |
| Pichelmann, MA | 1 |
| McIver, JI | 1 |
| McClelland, RL | 1 |
| Nichols, DA | 1 |
| Meyer, FB | 1 |
| Atkinson, JL | 1 |
| Wanke, I | 1 |
| Gizewski, E | 1 |
| Dörfler, A | 1 |
| Stolke, D | 1 |
| Paal, P | 1 |
| Putz, G | 1 |
| Gruber, E | 1 |
| Le, GT | 1 |
| Lemberger, P | 1 |
| Ries, T | 1 |
| Buhk, JH | 1 |
| Kucinski, T | 1 |
| Goebell, E | 1 |
| Grzyska, U | 1 |
| Zeumer, H | 1 |
| Fiehler, J | 1 |
| Dorhout Mees, SM | 1 |
| van Kooten, F | 1 |
| Dirven, CM | 1 |
| van Gijn, J | 2 |
| Vermeulen, M | 1 |
| Chan, MT | 1 |
| Choi, KC | 1 |
| Wong, GK | 1 |
| Poon, WS | 1 |
| Ducros, A | 1 |
| Choi, NK | 1 |
| Park, BJ | 1 |
| Jeong, SW | 1 |
| Yu, KH | 1 |
| Yoon, BW | 1 |
| Peluso, JP | 1 |
| van Rooij, WJ | 1 |
| Sluzewski, M | 1 |
| Beute, GN | 1 |
| Hans, GA | 1 |
| Senard, M | 1 |
| Ledoux, D | 1 |
| Grayet, B | 1 |
| Scholtes, F | 1 |
| Creemers, E | 1 |
| Lamy, ML | 1 |
| Barrow, MV | 1 |
| Quick, DT | 1 |
| Cunningham, RW | 1 |
| Rosove, MH | 1 |
| Ho, WG | 1 |
| Goldfinger, D | 1 |
| Warlow, CP | 1 |
| Mendelow, AD | 1 |
| Stockdill, G | 1 |
| Steers, AJ | 1 |
| Hayes, J | 1 |
| Gillingham, FJ | 1 |
| Toda, N | 1 |
| Ohta, T | 1 |
| Pickard, JD | 1 |
| Walker, V | 1 |
| Brandt, L | 1 |
| Zygmunt, S | 1 |
| Smythe, J | 1 |
| Pierot, L | 1 |
| Boulin, A | 1 |
| Castaings, L | 1 |
| Rey, A | 1 |
| Moret, J | 1 |
| Cole, DJ | 3 |
| Nary, JC | 2 |
| Reynolds, LW | 2 |
| Patel, PM | 3 |
| Drummond, JC | 3 |
| McKay, LD | 1 |
| Cross, LM | 1 |
| Jacobsen, WK | 1 |
| Iso, H | 1 |
| Hennekens, CH | 1 |
| Stampfer, MJ | 1 |
| Rexrode, KM | 1 |
| Colditz, GA | 1 |
| Speizer, FE | 1 |
| Willett, WC | 1 |
| Manson, JE | 1 |
| Hop, JW | 1 |
| Berkelbach van der Sprenkel, JW | 1 |
| Rasmussen, PA | 1 |
| Perl, J | 1 |
| Barr, JD | 1 |
| Markarian, GZ | 1 |
| Katzan, I | 1 |
| Sila, C | 1 |
| Krieger, D | 1 |
| Furlan, AJ | 1 |
| Masaryk, TJ | 1 |
| Reymond, MA | 1 |
| Marbet, G | 1 |
| Radü, EW | 1 |
| Gratzl, O | 1 |
| Donnan, GA | 1 |
| Warren, RD | 1 |
| Meyers, DS | 1 |
| Pape, BA | 1 |
| Maher, JF | 1 |
| Vroom, FQ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pharmacoepidemiological Study on the Risk of Bleeding in New Users of Low-dose Aspirin (ASA) in The Health Improvement Network (THIN), UK[NCT02550717] | 398,158 participants (Actual) | Observational | 2015-09-01 | Completed | |||
| Nurses' Health Study (Cardiovascular Component)[NCT00005152] | 121,700 participants (Actual) | Observational | 1980-08-31 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 reviews available for aspirin and Subarachnoid Hemorrhage
| Article | Year |
|---|---|
Associations Between Drug Treatments and the Risk of Aneurysmal Subarachnoid Hemorrhage: a Systematic Review and Meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Aspirin; Biguanides; Humans; Hydro | 2023 |
Association Between Aspirin Use and Risk of Aneurysmal Subarachnoid Hemorrhage: A Meta-analysis.
Topics: Aspirin; Humans; Platelet Aggregation Inhibitors; Subarachnoid Hemorrhage | 2020 |
Relationship between aspirin use and subarachnoid hemorrhage: A systematic Review and meta-analysis.
Topics: Aspirin; Case-Control Studies; Humans; Observational Studies as Topic; Platelet Aggregation Inhibito | 2021 |
A meta-analysis of aspirin and subarachnoid hemorrhage in patients with intracranial aneurysms yields different results to the general population.
Topics: Aneurysm, Ruptured; Aspirin; Humans; Intracranial Aneurysm; Prospective Studies; Stroke; Subarachnoi | 2022 |
Aspirin and Risk of Subarachnoid Hemorrhage: Systematic Review and Meta-Analysis.
Topics: Aspirin; Humans; Subarachnoid Hemorrhage | 2017 |
Unruptured Intracranial Aneurysms.
Topics: Aneurysm, Ruptured; Antihypertensive Agents; Aspirin; Cyclooxygenase Inhibitors; Disease Management; | 2018 |
Anti-thrombogenic coatings for devices in neurointerventional surgery: Case report and review of the literature.
Topics: Adult; Angiography, Digital Subtraction; Aspirin; Cerebral Angiography; Coated Materials, Biocompati | 2019 |
The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population--an updated meta-analysis.
Topics: Acute Disease; Asian People; Aspirin; Cerebral Hemorrhage; Cerebral Infarction; Chronic Disease; Cil | 2014 |
Potential role of aspirin in the prevention of aneurysmal subarachnoid hemorrhage.
Topics: Aneurysm, Ruptured; Animals; Aspirin; Brain; Humans; Intracranial Aneurysm; Intramolecular Oxidoredu | 2015 |
[Acute and chronic headaches].
Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspir | 2006 |
Cerebrovascular disease.
Topics: Anticoagulants; Antifibrinolytic Agents; Aspirin; Blood Platelets; Cerebrovascular Disorders; Fibrin | 1981 |
Therapy in cerebrovascular disease: current status and future directions.
Topics: Age Factors; Anticoagulants; Aspirin; Cerebral Infarction; Cerebrovascular Disorders; Forecasting; H | 1991 |
6 trials available for aspirin and Subarachnoid Hemorrhage
| Article | Year |
|---|---|
Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia.
Topics: Adult; Aged; Aspirin; Brain Ischemia; Case-Control Studies; Clopidogrel; Embolization, Therapeutic; | 2018 |
Magnesium and aspirin treatment in patients with subarachnoid haemorrhage. Comparison of effects after endovascular and neurosurgical aneurysm occlusion.
Topics: Aspirin; Brain Ischemia; Embolization, Therapeutic; Female; Humans; Intracranial Aneurysm; Magnesium | 2009 |
Effect of antiplatelet therapy for endovascular coiling in aneurysmal subarachnoid hemorrhage.
Topics: Aspirin; Data Collection; Female; Humans; Intraoperative Complications; Male; Middle Aged; Neurosurg | 2009 |
Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the MASH Study.
Topics: Aneurysm, Ruptured; Aspirin; Drug Administration Schedule; Female; Humans; Intracranial Aneurysm; Ma | 2006 |
Double-blind trial of aspirin in patient receiving tranexamic acid for subarachnoid hemorrhage.
Topics: Angiography; Aphasia; Aspirin; Double-Blind Method; Female; Hemiplegia; Humans; Intracranial Aneurys | 1982 |
Randomized pilot trial of postoperative aspirin in subarachnoid hemorrhage.
Topics: Aspirin; Brain; Female; Humans; Male; Middle Aged; Pilot Projects; Postoperative Period; Subarachnoi | 2000 |
67 other studies available for aspirin and Subarachnoid Hemorrhage
| Article | Year |
|---|---|
Aspirin and Subarachnoid Haemorrhage in the UK Biobank.
Topics: Aspirin; Biological Specimen Banks; Cohort Studies; Humans; Prospective Studies; Risk Factors; State | 2023 |
The association between acetylsalicylic acid and subarachnoid haemorrhage: the Framingham Heart Study.
Topics: Aspirin; Humans; Longitudinal Studies; Risk Factors; Smoking; Subarachnoid Hemorrhage | 2023 |
Aspirin and Intracranial Aneurysms.
Topics: Aneurysm, Ruptured; Animals; Aspirin; Female; Humans; Intracranial Aneurysm; Male; Subarachnoid Hemo | 2019 |
Warfarin Reinitiation After Intracranial Hemorrhage: A Case Series of Heart Valve Patients.
Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Aortic Valve; Aspirin; Blood Coagulation Factors; Cer | 2020 |
Is Aspirin a Worthy Candidate in Preventing Intracranial Aneurysm Rupture?
Topics: Aneurysm, Ruptured; Aspirin; Fibrinolytic Agents; Humans; Intracranial Aneurysm; Subarachnoid Hemorr | 2020 |
Dual antiplatelet therapy does not improve outcomes after aneurysmal subarachnoid hemorrhage compared with aspirin monotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Dual Anti-Platelet Therapy; Female; Humans; Mal | 2020 |
Flow diverter stents with hydrophilic polymer coating for the treatment of acutely ruptured aneurysms using single antiplatelet therapy: Preliminary experience.
Topics: Aneurysm, Ruptured; Angiography, Digital Subtraction; Aspirin; Cerebral Angiography; Coated Material | 2020 |
Letter to the Editor Regarding "Association Between Aspirin Use and Risk of Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis".
Topics: Aspirin; Humans; Hydrocephalus; Subarachnoid Hemorrhage | 2021 |
Prehemorrhage antiplatelet use in aneurysmal subarachnoid hemorrhage and impact on clinical outcome.
Topics: Aspirin; Glasgow Outcome Scale; Humans; Stroke; Subarachnoid Hemorrhage; Treatment Outcome | 2022 |
Incidence of intracranial bleeds in new users of low-dose aspirin: a cohort study using The Health Improvement Network.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cohort Studies; Female; Follow-Up Studies; Hematoma, Subdur | 2017 |
First US experience with Pipeline Flex with Shield Technology using aspirin as antiplatelet monotherapy.
Topics: Aneurysm, Ruptured; Angiography; Aspirin; Diffusion Magnetic Resonance Imaging; Embolization, Therap | 2017 |
Letter by Hasan et al Regarding Article, "Aspirin and Risk of Subarachnoid Hemorrhage: Systematic Review and Meta-Analysis".
Topics: Aspirin; Humans; Risk; Subarachnoid Hemorrhage | 2017 |
Low-dose aspirin and risk of intracranial bleeds: An observational study in UK general practice.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cerebral Hemorrhage; Cohort Studies; Dose-Response Relation | 2017 |
Continuous Acetylsalicylic Acid Treatment Does Not Influence Bleeding Pattern or Outcome of Aneurysmal Subarachnoid Hemorrhage: A Matched-Pair Analysis.
Topics: Aged; Aneurysm, Ruptured; Aspirin; Cerebral Hemorrhage; Cerebral Infarction; Female; Follow-Up Studi | 2018 |
Pre-admission use of platelet inhibitors and short-term stroke mortality: a population-based cohort study.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Denmark; Drug Th | 2018 |
Prevention Effect of Antiplatelets on Aneurysm Rupture in a Mouse Intracranial Aneurysm Model.
Topics: Aneurysm, Ruptured; Animals; Aspirin; Cerebral Arteries; Cilostazol; Cyclooxygenase 2; Cyclooxygenas | 2018 |
Pain medication at ictus of subarachnoid hemorrhage-the influence of one-time acetylsalicylic acid usage on bleeding pattern, treatment course, and outcome: a matched pair analysis.
Topics: Adult; Aged; Anticoagulants; Aspirin; Cerebral Infarction; Female; Fibrinolytic Agents; Headache; Ho | 2019 |
Association between aspirin dose and subarachnoid hemorrhage from saccular aneurysms: A case-control study.
Topics: Aneurysm; Aneurysm, Ruptured; Aspirin; Case-Control Studies; Dose-Response Relationship, Drug; Femal | 2018 |
Post-treatment Antiplatelet Therapy Reduces Risk for Delayed Cerebral Ischemia due to Aneurysmal Subarachnoid Hemorrhage.
Topics: Adult; Aged; Aspirin; Brain Ischemia; Case-Control Studies; Clopidogrel; Cohort Studies; Female; Hum | 2019 |
Journal Club: Association between aspirin dose and subarachnoid hemorrhage from saccular aneurysms: A case-control study.
Topics: Aneurysm, Ruptured; Aspirin; Case-Control Studies; Humans; Subarachnoid Hemorrhage | 2019 |
Reader response: Association between aspirin dose and subarachnoid hemorrhage from saccular aneurysms: A case-control study.
Topics: Aneurysm, Ruptured; Aspirin; Case-Control Studies; Humans; Subarachnoid Hemorrhage | 2019 |
Reader response: Association between aspirin dose and subarachnoid hemorrhage from saccular aneurysms: A case-control study.
Topics: Aneurysm, Ruptured; Aspirin; Case-Control Studies; Humans; Subarachnoid Hemorrhage | 2019 |
Author response: Association between aspirin dose and subarachnoid hemorrhage from saccular aneurysms: A case-control study.
Topics: Aneurysm, Ruptured; Aspirin; Case-Control Studies; Humans; Subarachnoid Hemorrhage | 2019 |
Aspirin and aneurysmal subarachnoid hemorrhage.
Topics: Adolescent; Aneurysm, Ruptured; Aspirin; Cerebral Angiography; Cohort Studies; Female; Humans; Male; | 2014 |
Risk of hemorrhagic complication associated with ventriculoperitoneal shunt placement in aneurysmal subarachnoid hemorrhage patients on dual antiplatelet therapy.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Female; Humans; Hydrocephalus; Intracranial An | 2013 |
Antithrombotic drugs and subarachnoid haemorrhage risk. A nationwide case-control study in Denmark.
Topics: Aged; Aspirin; Case-Control Studies; Clopidogrel; Denmark; Drug Therapy, Combination; Female; Fibrin | 2015 |
High prevalence of pharmacologically induced platelet dysfunction in the acute setting of brain injury.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Platelets; Brain Injuries; Cerebral Hemorrhage; Femal | 2016 |
Puerperal Extracranial Vertebral Artery Dissection and Nonaneurysmal Subarachnoid Hemorrhage.
Topics: Adult; Anticoagulants; Aspirin; Female; Humans; Neck Pain; Puerperal Disorders; Subarachnoid Hemorrh | 2016 |
The impact of aspirin and anticoagulant usage on outcomes after aneurysmal subarachnoid hemorrhage: a Nationwide Inpatient Sample analysis.
Topics: Adolescent; Adult; Aged; Anticoagulants; Aspirin; Drug Administration Schedule; Female; Hospital Mor | 2017 |
Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice.
Topics: Aneurysm, Ruptured; Animals; Aspirin; Cerebral Arteries; Cyclooxygenase 2; Cyclooxygenase Inhibitors | 2016 |
Use of aspirin as sole oral antiplatelet therapy in acute flow diversion for ruptured dissecting aneurysms.
Topics: Administration, Intravenous; Administration, Oral; Aneurysm, Ruptured; Aspirin; Embolization, Therap | 2017 |
Management of a Patient Requiring Intrathecal Drain Insertion and Removal in the Setting of Concomitant Dual Antiplatelet Therapy With Clopidogrel and Aspirin: A Case Report.
Topics: Aspirin; Catheters, Indwelling; Clopidogrel; Device Removal; Drainage; Drug Therapy, Combination; En | 2017 |
Recurrent perimesencephalic subarachnoid hemorrhage during antithrombotic therapy.
Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Cerebral Angiography; Fatal Outcome; Female; Hepar | 2009 |
A case of ecchordosis physaliphora presenting with an intratumoral hemorrhage.
Topics: Aspirin; Brain Diseases; Cranial Fossa, Posterior; Hamartoma; Headache; Humans; Magnetic Resonance I | 2009 |
Antiplatelet drugs and risk of subarachnoid hemorrhage: a population-based case-control study.
Topics: Adolescent; Adult; Aged; Aspirin; Case-Control Studies; Clopidogrel; Denmark; Dipyridamole; Female; | 2010 |
Superficial siderosis of the central nervous system: a rare cause of dementia with therapeutic consequences.
Topics: Aged; Aspirin; Dementia; Hemosiderosis; Humans; Magnetic Resonance Imaging; Male; Memory; Neuropsych | 2012 |
Predictors of hemorrhage volume and disability after perimesencephalic subarachnoid hemorrhage.
Topics: Adult; Aged; Aspirin; Cerebral Angiography; Cerebral Veins; Cerebrovascular Circulation; Cohort Stud | 2012 |
Incidence of cerebral ischemic events after discontinuation of clopidogrel in patients with intracranial aneurysms treated with stent-assisted techniques.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Clopidogrel; Cohort Studies; Drug Therapy, Combina | 2012 |
3 cases of primary intracranial hemorrhage associated with "Molly", a purified form of 3,4-methylenedioxymethamphetamine (MDMA).
Topics: Adult; Alcohol Drinking; Amphetamine-Related Disorders; Anticoagulants; Aspirin; Cerebral Angiograph | 2012 |
Treatment of blood blister-like aneurysms of the internal carotid artery with stent-assisted coil embolization.
Topics: Aspirin; Carotid Artery Diseases; Carotid Artery, Internal; Cerebral Angiography; Clopidogrel; Embol | 2013 |
Successful treatment of cerebral venous sinus thrombosis with the Solitaire FR thrombectomy device.
Topics: Anticoagulants; Aspirin; Cerebral Angiography; Endovascular Procedures; Female; Follow-Up Studies; H | 2013 |
Smoking and the risk of hemorrhagic stroke in men.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alcohol Drinking; Aspirin; beta Carotene; Body Mass Ind | 2003 |
Nonsteroidal anti-inflammatory drugs as risk factors for spontaneous intracerebral hemorrhage and aneurysmal subarachnoid hemorrhage.
Topics: Age Factors; Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bias; Case-Control | 2003 |
[Intracranial extension of extracranial vertebral artery dissections. A review of 16 cases].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Cerebral Angiography; Femal | 2004 |
Progressive cervicocranial arteriopathy with dilatations and stenoses: case report.
Topics: Adult; Arterial Occlusive Diseases; Aspirin; Basilar Artery; Carotid Artery Diseases; Carotid Artery | 2004 |
Influence of aspirin on outcome following aneurysmal subarachnoid hemorrhage.
Topics: Adult; Aged; Aspirin; Female; Humans; Incidence; Male; Medical Records; Middle Aged; Platelet Aggreg | 2004 |
[Stenting plus coiling: dangerous or helpful?].
Topics: Acute Disease; Aneurysm, Ruptured; Angiography, Digital Subtraction; Aspirin; Calcium Channel Blocke | 2005 |
Subarachnoid hemorrhage after lumbar puncture in a patient receiving aspirin and clopidrogel.
Topics: Anticoagulants; Aspirin; Clopidogrel; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Sp | 2006 |
Intravenous administration of acetylsalicylic acid during endovascular treatment of cerebral aneurysms reduces the rate of thromboembolic events.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cerebral Hemorrhage; Drug Evaluation; Embolization, Therape | 2006 |
Interaction between magnesium sulfate and acetylsalicylic acid in the MASH trial.
Topics: Aspirin; Brain Ischemia; Central Nervous System Agents; Drug Interactions; Humans; Magnesium Sulfate | 2007 |
Nonaspirin nonsteroidal anti-inflammatory drugs and hemorrhagic stroke risk: the Acute Brain Bleeding Analysis study.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Asian People | 2008 |
A new self-expandable nitinol stent for the treatment of wide-neck aneurysms: initial clinical experience.
Topics: Adult; Aged; Alloys; Aneurysm, Ruptured; Aspirin; Cerebral Angiography; Clopidogrel; Combined Modali | 2008 |
Cerebral subarachnoid blood migration consecutive to a lumbar haematoma after spinal anaesthesia.
Topics: Aged; Anesthesia, Spinal; Anesthetics, Intravenous; Anesthetics, Local; Angioplasty, Balloon; Arteri | 2008 |
Salicylate hypoprothrombinemia in rheumatoid arthritis with liver disease. Report of two cases.
Topics: Arthritis, Rheumatoid; Aspirin; Female; Hemorrhagic Disorders; Humans; Hypoprothrombinemias; Liver D | 1967 |
Ineffectiveness of aspirin and dipyridamole in the treatment of thrombotic thrombocytopenic purpura.
Topics: Adolescent; Adult; Aged; Aspirin; Dipyridamole; Epistaxis; Epoprostenol; Female; Gastrointestinal He | 1982 |
Mechanism of cerebral arterial contraction induced by blood constituents.
Topics: Animals; Aspirin; Cerebrovascular Circulation; Cinanserin; Dogs; Female; Hemoglobins; Ischemic Attac | 1980 |
Aspirin and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; Cerebral Infarction; Female | 1995 |
Effect of intraventricular haemorrhage and rebleeding following subarachnoid haemorrhage on CSF eicosanoids.
Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Brain Damage, Chronic; Cerebral Ventricles; Dexamethasone; Di | 1994 |
Endovascular treatment of pericallosal artery aneurysms.
Topics: Adult; Aneurysm, Ruptured; Aspirin; Cerebral Angiography; Corpus Callosum; Embolization, Therapeutic | 1996 |
Experimental subarachnoid hemorrhage in rats: effect of intravenous alpha-alpha diaspirin crosslinked hemoglobin on hypoperfusion and neuronal death.
Topics: Animals; Aspirin; Brain; Cell Death; Cerebrovascular Circulation; Exchange Transfusion, Whole Blood; | 1997 |
Subarachnoid molecular hemoglobin after subarachnoid hemorrhage in rats: effect on the area of hypoperfusion.
Topics: Analysis of Variance; Anesthetics, Inhalation; Animals; Antipyrine; Aspirin; Blood; Blood Substitute | 1998 |
Subarachnoid hemorrhage in rats: effect of singular or sustained hemodilution with alpha-alpha diaspirin crosslinked hemoglobin on cerebral hypoperfusion.
Topics: Animals; Aspirin; Blood Flow Velocity; Cerebrovascular Circulation; Disease Models, Animal; Drug Eva | 1999 |
Prospective study of aspirin use and risk of stroke in women.
Topics: Adult; Aspirin; Cerebrovascular Disorders; Cohort Studies; Female; Humans; Incidence; Middle Aged; P | 1999 |
Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: an initial experience.
Topics: Abciximab; Adult; Aged; Angiography; Angioplasty; Antibodies, Monoclonal; Anticoagulants; Aspirin; B | 2000 |
Aspirin as a risk factor for hemorrhage in patients with head injuries.
Topics: Adult; Aged; Aspirin; Brain Concussion; Cerebral Hemorrhage; Female; Hematoma, Epidural, Cranial; He | 1992 |
Fatal overdose of propoxyphene napsylate and aspirin. A case report with pathologic and toxicologic study.
Topics: Acute Disease; Adult; Aspirin; Autopsy; Brain Edema; Bronchitis; Dextropropoxyphene; Drug Combinatio | 1974 |
Stroke: malignant and benign syndromes.
Topics: Anticoagulants; Aspirin; Carotid Artery Diseases; Cerebral Hemorrhage; Cerebrovascular Disorders; De | 1973 |